Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.
Saved in:
| Title: | Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. |
|---|---|
| Authors: | Hackeng WM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Morsink FHM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Moons LMG; Department of Gastroenterology, University Medical Center Utrecht, Utrecht, The Netherlands., Heaphy CM; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland., Offerhaus GJA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Dreijerink KMA; Department of Endocrinology and Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. |
| Source: | Diagnostic cytopathology [Diagn Cytopathol] 2020 Apr; Vol. 48 (4), pp. 308-315. Date of Electronic Publication: 2019 Dec 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8506895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0339 (Electronic) Linking ISSN: 10970339 NLM ISO Abbreviation: Diagn Cytopathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0339 |
|---|---|
| DOI: | 10.1002/dc.24368 |
